Silicon Phthalocyanines Functionalized with Axial Substituents Targeting PSMA: Synthesis and Preliminary Assessment of Their Potential for PhotoDynamic Therapy of Prostate Cancer
ChemMedChem · 18.11.2024 · 19 (22)
DOI: 10.1002/cmdc.202400218 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 30.09.2024. Verfasst von Martina Capozza und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biotechnology and Health Sciences, University of Turin, Piazza Nizza 44bis, Torino, 10126, Italy. Hauptthemen laut MEDLINE: Photochemotherapy, Photosensitizing Agents, Prostatic Neoplasms, Organosilicon Compounds. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Photodynamic therapy (PDT) is a clinical modality based on the irradiation of different diseases, mostly tumours, with light following the selective uptake of a photosensitiser by the pathological tissue. In this study, two new silicon(IV)phtalocyanines (SiPcs) functionalized at both axial positions with a PSMA inhibitor are reported as candidate photosensitizers for PDT of prostate cancer, namely compounds SiPc‐PQ(PSMAi) 2 and SiPc‐OSi(PSMAi) 2 . These compounds share the same PSMA‐binding motif, but differ in the linker that connects the inhibitor moiety to the Si(IV) atom: an alkoxy (Si−O−C) bond for SiPc‐PQ(PSMAi) 2 , and a silyloxy (Si−O−Si) bond for SiPc‐OSi(PSMAi) 2 . Both compounds were synthesized by a facile synthetic route and fully characterized by 2D NMR, mass spectrometry and absorption/fluorescence spectrophotometry. The PDT agents showed a suitable solubility in water, where they essentially exist in monomeric form. SiPc‐PQ(PSMAi) 2 showed a higher singlet oxygen quantum yield Φ Δ , higher fluorescence quantum yields Φ F and better photostability than SiPc‐OSi(PSMAi) 2 . Both compounds were efficiently taken up by PSMA(+) PC3‐PIP cells, but not by PSMA(−) PC3‐FLU cells. However, SiPc‐PQ(PSMAi) 2 showed a more specific photoinduced cytotoxicity in vitro , which is likely attributable to a better stability of its water solutions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biotechnology and Health Sciences, University of Turin, Piazza Nizza 44bis, Torino, 10126, Italy.
- Department of Science and Technological Innovation, University of Eastern Piedmont "Amedeo Avogadro", Viale Teresa Michel 11, Alessandria, 15120, Italy.
ORCID-Profile: Martina Capozza, Giuseppe Digilio, Lorenzo Tei, Stefano Marchesi, Enzo Terreno, Rachele Stefania
Zitieren
APA
Capozza, M., Digilio, G., Gagliardi, M., Tei, L., Marchesi, S., Terreno, E., & Stefania, R. (2024). Silicon Phthalocyanines Functionalized with Axial Substituents Targeting PSMA: Synthesis and Preliminary Assessment of Their Potential for PhotoDynamic Therapy of Prostate Cancer. ChemMedChem, 19(22). https://doi.org/10.1002/cmdc.202400218
Vancouver
Capozza M, Digilio G, Gagliardi M, Tei L, Marchesi S, Terreno E, et al. Silicon Phthalocyanines Functionalized with Axial Substituents Targeting PSMA: Synthesis and Preliminary Assessment of Their Potential for PhotoDynamic Therapy of Prostate Cancer. ChemMedChem. 2024;19(22). doi:10.1002/cmdc.202400218
BibTeX
@article{Capozza2024,
author = {Capozza, Martina and Digilio, Giuseppe and Gagliardi, Michela and Tei, Lorenzo and Marchesi, Stefano and Terreno, Enzo and Stefania, Rachele},
title = {Silicon Phthalocyanines Functionalized with Axial Substituents Targeting PSMA: Synthesis and Preliminary Assessment of Their Potential for PhotoDynamic Therapy of Prostate Cancer},
journal = {ChemMedChem},
year = {2024},
volume = {19},
number = {22},
doi = {10.1002/cmdc.202400218}
}
EUVIMED